Prognostic and Clinicopathological Significance of Long Non-coding RNA PANDAR Expression in Cancer Patients: A Meta-Analysis

Background: Long non-coding RNA PANDAR is an emerging non-coding RNA mapping to 6p21.2. It underlies metastatic progression and chromosomal instability in a variety of cancers. Despite the fact that recent studies have revealed that lncRNA PANDAR may be a potential prognostic biomarker for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Lizhi, Wang, Bo, Wang, Ruoyu, Wang, Zijian, Gong, Song, Chen, Guo, Telemacque, Dionne, Feng, Yong, Xu, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901660/
https://www.ncbi.nlm.nih.gov/pubmed/31850222
http://dx.doi.org/10.3389/fonc.2019.01337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901660/
https://www.ncbi.nlm.nih.gov/pubmed/31850222
http://dx.doi.org/10.3389/fonc.2019.01337

Ejemplares similares